Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.5M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
+812K
-
Total reported value, excl. options
-
$312M
-
Value change
-
-$4.36M
-
Put/Call ratio
-
2.44
-
Number of buys
-
83
-
Number of sells
-
-59
-
Price
-
$13.72
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q2 2023
165 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q2 2023.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 28.5M outstanding shares and own 79.67% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS LP (3.09M shares), Granahan Investment Management, LLC (2.53M shares), BlackRock Inc. (2.13M shares), VANGUARD GROUP INC (1.43M shares), PRINCIPAL FINANCIAL GROUP INC (1.36M shares), Bellevue Group AG (1.12M shares), MILLENNIUM MANAGEMENT LLC (1.04M shares), KORNITZER CAPITAL MANAGEMENT INC /KS (648K shares), PALISADE CAPITAL MANAGEMENT, LP (602K shares), and STATE STREET CORP (535K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.